212. Deputy John Clendennen asked the Minister for Health if recent evidence from UK studies indicating that the shingrix (recombinant zoster) vaccine may reduce the risk of dementia and provide cognitive benefits has been considered in her Department’s assessment of the vaccine for inclusion in the national immunisation schedule; if these potential wider health benefits will be factored into future evaluations of the vaccine’s cost-effectiveness and public health value; and if she will make a statement on the matter. [34783/25]

Summary

212. Deputy John Clendennen asked the Minister for Health if recent evidence from UK studies indicating that the shingrix (recombinant zoster) vaccine may reduce the risk of dementia and provide cognitive benefits has been considered in her Department’s assessment of the vaccine for inclusion in the national immunisation schedule; if these potential wider health benefits will be factored into future evaluations of the vaccine’s cost-effectiveness and public health value; and if she will make a statement on the matter. [34783/25]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Vaccination Programme

  xml · EN · 25 June 2025

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.